Product Information
OPVEE 2.7 MG NASAL SPRAY is a brand product labeled by Indivior Inc., priced at $46.7887 per EA under NDC 12496000302. Its NADAC has been published 45 times since Aug 20, 2025.
Strength
2.7 mg/100uL
Manufacturer
Indivior Inc.NDC
12496000302
Classification
Brand
Dosage Form
SPRAY
Route
NASAL
Last Updated
6/17/2026
Active Ingredients
NALMEFENE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA217470On Market Since
10/2/2023
Pharmacological Classes
Price Statistics
The NADAC for OPVEE 2.7 MG NASAL SPRAY has been published 45 times since Aug 20, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $46.7887 per EA |
|---|---|
| All-time high | $46.8392 (Apr 15, 2026) |
| All-time low | $46.7321 (Oct 22, 2025) |
| 52-week high | $46.8392 |
| 52-week low | $46.7321 |
| Median price | $46.7839 |
| Average price | $46.7902 |
| Largest weekly change | -0.2% (Oct 22, 2025) |
| Weeks tracked | 45 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the nalmefene hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OPVEE 2.7 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for OPVEE 2.7 MG NASAL SPRAY, manufactured by Indivior Inc., is $46.7887 per EA (NDC 12496000302), effective Jun 24, 2026.
How has the price of OPVEE 2.7 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for OPVEE 2.7 MG NASAL SPRAY has held within roughly two percent of its current level. It has been tracked across 45 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for OPVEE 2.7 MG NASAL SPRAY?
Since Aug 20, 2025, the NADAC for OPVEE 2.7 MG NASAL SPRAY has ranged from a low of $46.7321 (Oct 22, 2025) to a high of $46.8392 (Apr 15, 2026), with a median of $46.7839 per EA.
Are there cheaper alternatives to OPVEE 2.7 MG NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OPVEE 2.7 MG NASAL SPRAY, so no direct lower-cost alternative is listed.
Who manufactures OPVEE 2.7 MG NASAL SPRAY?
OPVEE 2.7 MG NASAL SPRAY (NDC 12496000302) is labeled by Indivior Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification